Association between orofacial granulomatosis and Crohn's disease in children: Systematic review

Marzia Lazzerini, Matteo Bramuzzo, Alessandro Ventura

Research output: Contribution to journalArticle

Abstract

AIM: To review pediatric cases of orofacial granulomatosis (OFG), report disease characteristics, and explore the association between OFG and Crohn's disease. METHODS: We conducted a systematic review according to the PRISMA guidelines. We searched Medline, LILACS, Virtual Health Library, and Web of Knowledge in September 2013 for cases of OFG in the pediatric age range (<18 years), with no language limitations. All relevant articles were accessed in full text. The manual search included references of retrieved articles. We extracted data on patients' characteristics, disease characteristics, association with other diseases, and treatment. We analyzed the data and reported the results in tables and text. RESULTS: We retrieved 173 reports of OFG in children. Mean age at onset was 11.1 ± 3.8 years (range: 2.0-18 years). Prevalence in males was significant higher than in females (P <0.001), with a male:female ratio of 2:1. Gastrointestinal signs or symptoms were present in 26.0% of children at the time of OFG diagnosis. Overall, 70/173 (40.4%) children received a concomitant diagnosis of Crohn's disease. In about half (51.4%) of the cases the onset of OFG anticipated the diagnosis of Crohn's disease, with a mean time between the two diagnoses of 13.1 ± 11.6 mo (range: 3-36 mo). Overall, 21/173 (12.1%) of the children with OFG had perianal disease, while 11/173 (6.4%) had a family history of Crohn's disease. Both perianal disease and a family history of Crohn's disease were significantly associated with a higher risk of Crohn's disease diagnosis in children with OFG [relative risk (RR) = 3.10, 95% confidence interval (CI): 2.46-3.90; RR = 2.74, 95%CI: 2.24-3.36, P <0.0001 for both). Treatment of OFG included steroids (70.8% of children) and other immunosuppressive drugs (42.7%), such as azathioprine, thalidomide and infliximab. CONCLUSION: High prevalence of Crohn's disease in children with OFG suggests that OFG may be a subtype of Crohn's disease.

Original languageEnglish
Pages (from-to)7497-7504
Number of pages8
JournalWorld Journal of Gastroenterology
Volume20
Issue number23
DOIs
Publication statusPublished - Jun 21 2014

Fingerprint

Orofacial Granulomatosis
Crohn Disease
Digital Libraries
Confidence Intervals
Pediatrics
Thalidomide
Azathioprine
Immunosuppressive Agents
Age of Onset

Keywords

  • Cheilitis granulomatosa
  • Children
  • Crohn's disease
  • Melkersson-Rosenthal syndrome
  • Orofacial granulomatosis
  • Systematic review

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Association between orofacial granulomatosis and Crohn's disease in children : Systematic review. / Lazzerini, Marzia; Bramuzzo, Matteo; Ventura, Alessandro.

In: World Journal of Gastroenterology, Vol. 20, No. 23, 21.06.2014, p. 7497-7504.

Research output: Contribution to journalArticle

@article{e06d492f0af44a2e8744678d9d4d904b,
title = "Association between orofacial granulomatosis and Crohn's disease in children: Systematic review",
abstract = "AIM: To review pediatric cases of orofacial granulomatosis (OFG), report disease characteristics, and explore the association between OFG and Crohn's disease. METHODS: We conducted a systematic review according to the PRISMA guidelines. We searched Medline, LILACS, Virtual Health Library, and Web of Knowledge in September 2013 for cases of OFG in the pediatric age range (<18 years), with no language limitations. All relevant articles were accessed in full text. The manual search included references of retrieved articles. We extracted data on patients' characteristics, disease characteristics, association with other diseases, and treatment. We analyzed the data and reported the results in tables and text. RESULTS: We retrieved 173 reports of OFG in children. Mean age at onset was 11.1 ± 3.8 years (range: 2.0-18 years). Prevalence in males was significant higher than in females (P <0.001), with a male:female ratio of 2:1. Gastrointestinal signs or symptoms were present in 26.0{\%} of children at the time of OFG diagnosis. Overall, 70/173 (40.4{\%}) children received a concomitant diagnosis of Crohn's disease. In about half (51.4{\%}) of the cases the onset of OFG anticipated the diagnosis of Crohn's disease, with a mean time between the two diagnoses of 13.1 ± 11.6 mo (range: 3-36 mo). Overall, 21/173 (12.1{\%}) of the children with OFG had perianal disease, while 11/173 (6.4{\%}) had a family history of Crohn's disease. Both perianal disease and a family history of Crohn's disease were significantly associated with a higher risk of Crohn's disease diagnosis in children with OFG [relative risk (RR) = 3.10, 95{\%} confidence interval (CI): 2.46-3.90; RR = 2.74, 95{\%}CI: 2.24-3.36, P <0.0001 for both). Treatment of OFG included steroids (70.8{\%} of children) and other immunosuppressive drugs (42.7{\%}), such as azathioprine, thalidomide and infliximab. CONCLUSION: High prevalence of Crohn's disease in children with OFG suggests that OFG may be a subtype of Crohn's disease.",
keywords = "Cheilitis granulomatosa, Children, Crohn's disease, Melkersson-Rosenthal syndrome, Orofacial granulomatosis, Systematic review",
author = "Marzia Lazzerini and Matteo Bramuzzo and Alessandro Ventura",
year = "2014",
month = "6",
day = "21",
doi = "10.3748/wjg.v20.i23.7497",
language = "English",
volume = "20",
pages = "7497--7504",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "23",

}

TY - JOUR

T1 - Association between orofacial granulomatosis and Crohn's disease in children

T2 - Systematic review

AU - Lazzerini, Marzia

AU - Bramuzzo, Matteo

AU - Ventura, Alessandro

PY - 2014/6/21

Y1 - 2014/6/21

N2 - AIM: To review pediatric cases of orofacial granulomatosis (OFG), report disease characteristics, and explore the association between OFG and Crohn's disease. METHODS: We conducted a systematic review according to the PRISMA guidelines. We searched Medline, LILACS, Virtual Health Library, and Web of Knowledge in September 2013 for cases of OFG in the pediatric age range (<18 years), with no language limitations. All relevant articles were accessed in full text. The manual search included references of retrieved articles. We extracted data on patients' characteristics, disease characteristics, association with other diseases, and treatment. We analyzed the data and reported the results in tables and text. RESULTS: We retrieved 173 reports of OFG in children. Mean age at onset was 11.1 ± 3.8 years (range: 2.0-18 years). Prevalence in males was significant higher than in females (P <0.001), with a male:female ratio of 2:1. Gastrointestinal signs or symptoms were present in 26.0% of children at the time of OFG diagnosis. Overall, 70/173 (40.4%) children received a concomitant diagnosis of Crohn's disease. In about half (51.4%) of the cases the onset of OFG anticipated the diagnosis of Crohn's disease, with a mean time between the two diagnoses of 13.1 ± 11.6 mo (range: 3-36 mo). Overall, 21/173 (12.1%) of the children with OFG had perianal disease, while 11/173 (6.4%) had a family history of Crohn's disease. Both perianal disease and a family history of Crohn's disease were significantly associated with a higher risk of Crohn's disease diagnosis in children with OFG [relative risk (RR) = 3.10, 95% confidence interval (CI): 2.46-3.90; RR = 2.74, 95%CI: 2.24-3.36, P <0.0001 for both). Treatment of OFG included steroids (70.8% of children) and other immunosuppressive drugs (42.7%), such as azathioprine, thalidomide and infliximab. CONCLUSION: High prevalence of Crohn's disease in children with OFG suggests that OFG may be a subtype of Crohn's disease.

AB - AIM: To review pediatric cases of orofacial granulomatosis (OFG), report disease characteristics, and explore the association between OFG and Crohn's disease. METHODS: We conducted a systematic review according to the PRISMA guidelines. We searched Medline, LILACS, Virtual Health Library, and Web of Knowledge in September 2013 for cases of OFG in the pediatric age range (<18 years), with no language limitations. All relevant articles were accessed in full text. The manual search included references of retrieved articles. We extracted data on patients' characteristics, disease characteristics, association with other diseases, and treatment. We analyzed the data and reported the results in tables and text. RESULTS: We retrieved 173 reports of OFG in children. Mean age at onset was 11.1 ± 3.8 years (range: 2.0-18 years). Prevalence in males was significant higher than in females (P <0.001), with a male:female ratio of 2:1. Gastrointestinal signs or symptoms were present in 26.0% of children at the time of OFG diagnosis. Overall, 70/173 (40.4%) children received a concomitant diagnosis of Crohn's disease. In about half (51.4%) of the cases the onset of OFG anticipated the diagnosis of Crohn's disease, with a mean time between the two diagnoses of 13.1 ± 11.6 mo (range: 3-36 mo). Overall, 21/173 (12.1%) of the children with OFG had perianal disease, while 11/173 (6.4%) had a family history of Crohn's disease. Both perianal disease and a family history of Crohn's disease were significantly associated with a higher risk of Crohn's disease diagnosis in children with OFG [relative risk (RR) = 3.10, 95% confidence interval (CI): 2.46-3.90; RR = 2.74, 95%CI: 2.24-3.36, P <0.0001 for both). Treatment of OFG included steroids (70.8% of children) and other immunosuppressive drugs (42.7%), such as azathioprine, thalidomide and infliximab. CONCLUSION: High prevalence of Crohn's disease in children with OFG suggests that OFG may be a subtype of Crohn's disease.

KW - Cheilitis granulomatosa

KW - Children

KW - Crohn's disease

KW - Melkersson-Rosenthal syndrome

KW - Orofacial granulomatosis

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84902664458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902664458&partnerID=8YFLogxK

U2 - 10.3748/wjg.v20.i23.7497

DO - 10.3748/wjg.v20.i23.7497

M3 - Article

C2 - 24966621

AN - SCOPUS:84902664458

VL - 20

SP - 7497

EP - 7504

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 23

ER -